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Through linkage analysis and candidate gene sequencing, we identiﬁed three unrelated families with the autosomal-dominant inheri-
tance of early onset anemia, hypouricosuric hyperuricemia, progressive kidney failure, and mutations resulting either in the deletion
(p.Leu16del) or the amino acid exchange (p.Leu16Arg) of a single leucine residue in the signal sequence of renin. Both mutations
decrease signal sequence hydrophobicity and are predicted by bioinformatic analyses to damage targeting and cotranslational translo-
cation of preprorenin into the endoplasmic reticulum (ER). Transfection and in vitro studies conﬁrmed that both mutations affect ER
translocation and processing of nascent preprorenin, resulting either in reduced (p.Leu16del) or abolished (p.Leu16Arg) prorenin and
renin biosynthesis and secretion. Expression of renin and other components of the renin-angiotensin systemwas decreased accordingly
in kidney biopsy specimens from affected individuals. Cells stably expressing the p.Leu16del protein showed activated ER stress,
unfolded protein response, and reduced growth rate. It is likely that expression of the mutant proteins has a dominant toxic effect
gradually reducing the viability of renin-expressing cells. This alters the intrarenal renin-angiotensin system and the juxtaglomerular
apparatus functionality and leads to nephron dropout and progressive kidney failure. Our ﬁndings provide insight into the functionality
of renin-angiotensin system and stress the importance of renin analysis in families and individuals with early onset hyperuricemia,
anemia, and progressive kidney failure.Introduction
The physiologic importance of the renin-angiotensin
system (RAS) has been well described in more than
25,000 medical publications, with substantial interest in
the effect of angiotensin converting enzyme gene poly-
morphisms on renal function.1 Recessive mutations
causing complete loss of renin synthesis resulting in renal
tubular dysgenesis (RTD [MIM 267430]) have been
described.2 With the exception of premature stop codon
mutation leading to benign hyperproreninemia3 (REN
[MIM 179820]), no other nonlethal mutations of the renin
gene have been reported to date. Identiﬁcation and charac-
terization of such mutations may provide unique insight
into the physiology of the RAS and its organ-speciﬁc func-
tionality and regulation. The gene responsible for renin
production is located on chromosome 1, and it is primarily
expressed by granular cells in the juxtaglomerular appa-
ratus of the kidney. The gene product preprorenin contains
a signal sequence that directs ER targeting, glycosylation,204 The American Journal of Human Genetics 85, 204–213, Augustand proteolytic processing of the nascent preproprotein,
resulting in prorenin and renin production.4 A primary
function of renin is the hydrolytic cleavage of angiotensi-
nogen to angiotensin, with the subsequent stimulation
of aldosterone production. The RAS has also been found
to have widespread and diverse roles, including modu-
lating vascular tone, renal sodium handling, erythropoi-
esis, thirst, cardiac hypertrophy, and functioning through
local RAS systems in many organs.5
In this work, by using positional cloning, we identify
two unrelated families with mutations resulting in the
deletion (p.Leu16del) of a single leucine residue in the
signal sequence of renin. On the other hand, renin muta-
tion (p.Leu16Arg) in the third family was detected through
a candidate gene approach based on the association of
anemia and hyperkalemia with low-normal and orthosta-
tism-unresponsive plasma renin concentration (PRC) and
aldosterone levels in the proband.
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mutations suggested that juxtaglomerular cells, sustaining
the highest expression rate of the mutant protein expres-
sion, are likely exposed to chronic ER stress and unfolded
protein response. This led to site-speciﬁc attenuation of
reninbiosynthesis, RASdysregulation, andaltered juxtaglo-
merular apparatus functionality that result in a newly
described clinical syndrome characterized by early-onset
anemia, hyperuricemia, and progressive kidney failure.
Material and Methods
Patients
Family A was ascertained at the Department of Nephrology at the
University Hospital in Leuven and was described, labeled as BE1,
in our previous studies.6,7 Families B and C were ascertained at
the Section on Nephrology, Wake Forest University School of
Medicine (Winston-Salem, NC) and Nephrology and Transplanta-
tion Unit, Henri Mondor Hospital (Creteil, France), respectively.
Medical histories were obtained as a part of all the patients’ clinical
work-up by consultants of the above referred institutions. Investi-
gations were approved by the participating center’s Institutional
Review Boards and were conducted according to the Declaration
of Helsinki principles.
Genotyping, Linkage Analysis, and DNA Sequencing
Members of family A were genotyped with Affymetrix GeneChip
Mapping 10K 2.0 Xba Arrays. Multipoint parametric linkage anal-
ysis, along with determination of the most likely haplotypes, was
carried out under the assumption of a dominant mode of inheri-
tance with a 0.99 constant, age-independent penetrance, 0.01
phenocopy rate, and 0.001 frequency of disease allele. Genomic
fragments covering promoter region (about 500 bp upstream
from most cDNA 50 end) and all of the exons and exon-intron
boundaries of selected candidate genes were PCR ampliﬁed from
genomic DNA and sequenced in single proband and healthy indi-
vidual from family A. The renin gene (REN) was analyzed in all
three families as previously described.2,8 Segregation of RENmuta-
tions in the families and absence of the mutations in a control
white population were assessed by combination of genotyping
and direct sequencing of the corresponding genomic DNA frag-
ment. Disease haplotypes in families A and B were assessed with
a set of microsatellite markers ﬂanking the REN region.
In Silico Analysis
Preprorenin signal sequences from the presented species were
obtained from the UniProtKB/Swiss-Prot database. Multiple align-
ment and evaluation of the amino acids conservation were per-
formed by ClustalW2 software (EMBL-EBI database). Properties
of the signal sequences were assessed with the SignalP 3.0 server9
and the Kyte and Doolittle method.10
REN cDNA Expression Constructs
Wild-type REN mRNA was reverse transcribed from human total
kidney RNA, PCR ampliﬁed, and cloned into pCR3.1 vector (Invitro-
gen,Paisley,UK).Constructswere introduced into theEscherichia coli
TOP 10’F strain (Invitrogen, Paisley, UK) and the wild-type (WTREN)
clones were selected by sequencing. Mutant construct c.45_47
delGCT (DL16REN)was prepared by subcloning of the corresponding
DNAfragments into theWTREN/pCR3.1construct.Mutantconstruct
c.47T>G (L16RREN) was prepared by site-directed mutagenesis.The AmerTransient Expression of REN
HEK293 cells were maintained in DMEM high-glucose medium
supplemented with 10% (vol/vol) fetal calf serum (PAA), 100 U/ml
penicillin G (Sigma, Prague, Czech Republic), and 100 mg/ml strep-
tomycin sulfate (PAA Laboratories GmbH, Pashing, Austria). Trans-
fections were carried out with Lipofectamine 2000 (Invitrogen,
Paisley, UK) with either 1.5 mg or 4 mg DNA for 1.5 3 105 or 8 3
105 cells, respectively.
REN-Expressing Stable Cell Lines
HEK293 cells were maintained as described above and transfected
at 85% conﬂuence with Amaxa nucleofector system (Amaxa, Ko¨ln,
Germany). Three days after nucleofection, cells were trypsinized,
diluted, and cultured in selective medium containing 0.8 mg/ml
G418 (Invitrogen-GIBCO, Paisley, UK). REN-expressing clones
were selected with PCR, sequencing, and western blot analyses.
In Vitro Translation and Translocation
Wild-type (WTREN), c.45_47delGCT (DL16REN), and c.47T>G
(L16RREN) encoding plasmid DNA were linearized, puriﬁed, and
used for in vitro transcription with T7 polymerase as described
before.11 Invitro translationwasperformedwith rabbit reticulocyte
lysate (Promega,Mannheim,Germany) and [35S] EasyTag EXPRESS
Protein LabelingMix (Perkin Elmer, Rodgau Ju¨gesheim, Germany).
Reactionswere incubated at 30C for 30min in the absence or pres-
ence of 1 eqMicrococcus nuclease-treated rough microsomes (RMs)
produced according to the protocol ofWalter and Blobel.12 In vitro
reactions were either directly precipitated or the membranes were
separated by centrifugation through a sucrose cushion as described
elsewhere.13 Translation products were separated in 10% SDS gels
(T: 10%, C: 0.8% according to La¨mmli) or in Tris/Bicine gels.14
Prorenin and Renin Analysis
Western Blot Analysis and Deglycosylation Studies
Cells were grown in standard, serum-supplemented medium.
24 hr before the analyses, the supplementedmediumwas replaced
by serum-free medium. For secreted renin analysis, the medium
was collected and centrifuged ﬁrst at 800 3 g/5 min and then at
15,0003 g/5 min for residual cells and cellular debris removal. Re-
sulting supernatant was mixed with protease inhibitor cocktail
(Sigma, Prague, Czech Republic) in ratio 100:1 (vol/vol). 500 ml
of the medium was then concentrated on Microcon YM-10 ﬁlters
(Millipore, Billerica, MA), and total protein was recovered and
dissolved in SDS sample buffer. Harvested cells were resuspended
in PBS containing protease inhibitor cocktail, sonicated 2 times
for 30 s on ice, and centrifuged for 15,000 3 g/5 min. Pellet was
dissolved in SDS sample buffer. Denatured protein samples were
separated on 13% SDS-PAGE, blotted onto PVDF membrane,
probed with rabbit anti-preprorenin (recognizing amino acid resi-
dues 21–64) antibody (Yanaihara, Shizuoka, Japan), and detected
with anti-rabbit IgG antibody conjugated to horseradish peroxi-
dase (Pierce, Rockford, IL). Deglycosylation experiments were
performed on protein extracts and cell lysates with the GlycoPro
enzymatic deglycosylation kit (ProZyme Inc., San Leandro, CA).
Deglycosylated products were analyzed by SDS-PAGE and western
blot as described above.
Quantitative Renin Measurement
Cell lysate was prepared as described above. The medium was
centrifuged at 15,000 3 g for 5 min and resulting supernatant
was mixed with protease inhibitor cocktail in ratio 100:1 (vol/vol).
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diluted to ﬁnal volume of 200 ml with PBS. For trypsin-activated
total renin and prorenin amount, 5 ml of medium and 2.5 ml of
lysate were incubated at 37C for 30 min in a 50 ml PBS reactions
containing 20 mg and 5 mg of trypsin, respectively. The reactions
were stopped by 1 ml of 10 mg/mL trypsin inhibitor (PMSF, Roche,
Prague, Czech Republic) and diluted to a ﬁnal volume of 200 ml
with PBS. 10 ml of the resulting mixtures were mixed with 190 ml
of PBS and 100 ml of the anti-hRenin (I-125) reagent (Active Renin
IRMA kit, DSL, Webster, TX), and the renin amount was measured
according to manufacturer instructions.
Renin Secretion Measurement
Stably transfected HEK293 cells were cultured in 96-well plates in
standard, serum-supplementedmediumwithout phenol red. After
20 hr, the medium was replaced with medium containing renin
substrate conjugated with 5-FAM and QXL520 (part of SensoLyte
520 Renin Assay Kit, AnaSpec, San Jose, CA). Fluorescent signal
was monitored at 520 nm every 5 min for 8 hr at 37C on Synergy
2 microplate reader (BioTek, Winooski, VT).
Immunofluorescence Analysis
Transfected HEK293 cells were grown on glass chamber slides (BD
Falcon - 4Chamber Polystyrene Vessel Tissue Culture Treated
Glass Slide). After 48 hr, the cells were washed with PBS, ﬁxed with
100% ice-cold methanol, blocked with 5% FBS, and incubated
with rabbit anti-preprorenin (288-317) antibodies. Organelle-
speciﬁc primary antibodies and ﬂuorescently labeled secondary
antibodies were described previously.7 Nuclei were stained with
40,6-diamidino-2-phenylindole (DAPI). Prepared slides were
mounted in ﬂuorescence mounting medium Immu-Mount (Shan-
donLipshaw,Pittsburgh, PA)andanalyzedbyconfocalmicroscopy.7
Growth Rate Analysis
Stably transfected HEK293 cells were seeded in a 6-well plate at
4 3 105 cells per well and cultured in the selective, G418-contain-
ing medium. Cells were counted every 24 hr for 7 days via a stan-
dard Bu¨rker cell counting chamber. The medium was changed at
the third, ﬁfth, and sixth days.
Figure 1. Pedigrees, Linkage and DNA
Analysis
(A) Pedigrees of the investigated families.
Black symbols denote affected individuals;
open symbols denote unaffected individ-
uals; and gray symbols denote individuals
inwhomclinical, biochemical, and genetic
investigations were not yet performed.
(B) A whole-genome parametric linkage
analysis showing a single statistically
signiﬁcant region on chromosome 1q41
detected in family A.
(C) Chromatograms showing genomic
DNA sequence of theREN exon1 in control
and a heterozygous deletion c.45_47
delGCT in patient from family A.
(D) Chromatograms showing genomic
DNA sequence of theREN exon1 in control
and a heterozygous mutation c.47T>G in
patient from family C.
XBP1 Analysis
Total RNA was isolated from cells via TRI-
ZOL (Invitrogen, Carlsbad, CA) and reverse
transcribed with oligo-dT primer and
SuperScript II (Invitrogen). XBP1 was PCR
ampliﬁed from the corresponding cDNA with gene-speciﬁc
primers.
Electron Microscopy
Pellets of stably transfected HEK293 cells were ﬁxed with 3%
glutaraldehyde in 0.1 M phosphate buffer for 30 min, postﬁxed
with buffered 1% OsO4 for 2 hr, dehydrated, and embedded into
Epon. Thin sections were double contrasted with uranyl acetate
and lead nitrate. Grids were observed and photographs were ob-
tained on JEOL 1200 electron microscope.
Immunohistochemistry Studies
Formaldehyde- or ethanol-ﬁxed kidney samples from 5 controls
and patients DII1, DIV3, and DIV7 were analyzed essentially as
previously described.7 Selected antigens were investigated with
the following primary antibodies: prorenin, rabbit anti-preprore-
nin (amino acid residues 21–64); prorenin þ renin, rabbit anti-
preprorenin (amino acid residues 288–317), both (Yanaihara,
Shizuoka, Japan); active renin, mouse anti-renin (clone R3-36-
16, gift from Novartis AG, Basel Switzerland); Pro/renin receptor,
rabbit anti-/P/RR (gift from Genevieve Nguyen, Paris); angiotensi-
nogen, mouse anti-angiotensinogen (US Biological, Swampscott,
MA); angiotensin II, mouse anti-angiotensin II (Acris, Herford,
Germany). Immunohistochemical detection of renin and in situ
detection of renin mRNA in kidney biopsy from Family C patient
CIII1 was performed as previously described.2
Results
Clinical and Biochemical Findings
In this work, we analyzed three families with the auto-
somal-dominant inheritance of chronic progressive
kidney failure (Figure 1A). All three families were of Euro-
pean ancestry, by family report. In Family A, the youngest206 The American Journal of Human Genetics 85, 204–213, August 14, 2009
Figure 2. Renin Immunohistochemistry
and Nephropathology
Family A, patients DIV3, DIV7, and DII1.
(A–C) Renin expression in control kidney.
(A) Control aged 7 years; renin expression
in JG cells and individual cells of collecting
ducts.
(B and C) Adult control; renin staining (B)
in JG cells and (C) in renal cortical tubules
where the signal is restricted to individual
cells of the collecting ducts.
(D and E) Kidney biopsies in an early
disease stage. Patient DIV3 (D) and patient
DIV7 (E) shown. The common denomi-
nator is a strong reduction of renin signal
in the JG apparatus (marked by arrows)
and its absence in the surrounding tubules.
Insert in (E) shows glomerulus in detail.
(F) Patient in advanced stage of kidney
disease (DII1). Renin staining is absent in
both JG apparatus and tubular epithelium
even in relatively well-preserved regions.
(G–I) Renin and prorenin expression inside
the wall of small size renal vessels, prob-
ably in a sub/endothelial localization,
more prominent in adult patient DII1
(the main pictures) than in patients in an
early stage of the disease (inserts). Prepror-
enin antibody detecting prorenin and
renin (G), monoclonal antibody detecting
active renin (H), and polyclonal antibody
detecting prorenin (I). Insert in (G) demon-
strates this phenomenon in patient DIV7,
inserts in (H) and (I) in patient DIV3.
(J–L) Nephropathology in early stage of
the disease (HE staining).
(J) Morphology in patient DIV3 was dominated by irregular dystrophic changes in tubular epithelium mainly in proximal tubules
(coarsely vacuolated or granular cytoplasm) and focal segmental sclerosis of glomerular tufts with adhesions to Bowman’s capsule.
Tubular atrophy and interstitial ﬁbrosis was less expressed (sampling?).
(K and L) Kidney biopsy from patient DIV7 demonstratedmore pronounced glomerular sclerosis and hyalinosis (1 out of 8 glomeruli was
totally sclerosed, not shown) and focal tubular atrophy accompanied with moderate interstitial ﬁbrosis. Glomeruli, marked as Gs, in
various degrees of sclerosis and areas of tubulointerstitial ﬁbrosis are shown. In advanced stage of the disease (patient DII1, not shown),
morphology of progressive nephropathy was modiﬁed by haemodialysis lasting for 1 year.family member (DIV7) was studied at age of 4 years, at
which time the patient was asymptomatic. The blood pres-
sure was 92/50 mm Hg. Physical examination was unre-
markable. Laboratory studies revealed a hemoglobin level
of 9.5 g/dl (normal 11.5–13.5 g/dl), serum uric acid level
of 6.0 mg/dl (normal 1.8–5.4 mg/dl), and an inulin clear-
ance of 68 ml/min/1.73 m2. Renal ultrasound performed
at 7 years revealed kidney sizes of 7.4 and 6.9 cm (normal
8.5–11.5 cm) with no evidence of cyst formation. Kidney
biopsy revealed focal tubular atrophy and dystrophy, focal
and segmental glomerular sclerosis, and interstitial ﬁbrosis
(Figures 2K and 2L). The patient was started on allopurinol
and followed with annual laboratory studies. The serum
potassium values ranged between 4.8 and 5.9 mEq/l with
serum bicarbonate levels between 19.6 and 25 mEq/l.
Plasma renin and aldosterone levels were low but not
entirely suppressed. Very similar clinical presentation
and biochemical data were observed in all affected individ-
uals in the three families (Table 1). Hemoglobin values
were consistently low in children with the disease, with
hemoglobin measurement at age 1 year in BIV2 alreadyThe Amerlow at 10.2 g/dl. However, affected adults in the 4th and
5th decades of life had normal hemoglobin values if renal
failure was not severe. Individuals with anemia had low
reticulocyte counts and normal mean corpuscular volume.
B12 and folate levels were normal in those who were
studied. Individuals had normal iron stores or remained
anemic after iron was repleted. Bone marrow aspirate
was normal in an anemic individual from Family A.
Anemia responded well to erythropoietin. There was a
tendency to hyperkalemia in some individuals, though
this was a variable ﬁnding. Hyperuricemia was present in
many but not all patients, and the fractional excretion of
uric acid was low in all individuals studied. Uric acid excre-
tion and proteinuria stayed quite constant over time.
Renal disease was characterized by a bland urinalysis and
absence of proteinuria. Reduced glomerular ﬁltration was
present from an early age and developed in all affected
individuals. Kidney failure was slowly progressive with
end-stage kidney disease developing at ages 50, 66, and
68 years in Family A, and at ages 43, 50, and 63 years in
Family B.ican Journal of Human Genetics 85, 204–213, August 14, 2009 207
Hemoglobin
(g/L)g
Random Plasma
Renin Activity
(ng/ml/h)h
Random
serum
Aldosterone
(ng/dl)i
Renal Size Left,
Right Kidney
(Age of
Measurement)
9.5 7.4, 6.9 (7)
12.9 0.5 25 8.2, 8.3 (16)
10.2 8.7, 8.0 (10)
10.9 2.2 15 9.9, 10.9 (19)
11.5 1.6 18
13.1 0.6 23 10.7, 10.5 (47)
10.1 1.7 2.8
15.7
13.1 2.6 6.0
10.8 0.4 6.4 10.3, 9.0 (58)
9.9
10.9
8.3n 10.3 mU/Lo 21 9.5, 10.0 (18)
13.0
13.0
15.3
6 years, 2.7–6.3 mg/dl.
for male adult.
2
0
8
T
h
e
A
m
e
rica
n
Jo
u
rn
a
l
o
f
H
u
m
a
n
G
e
n
e
tics
8
5
,
2
0
4
–
2
1
3
,
A
u
g
u
st
1
4
,
2
0
0
9Table 1. Representative Clinical and Biochemical Findings in Affected Family Members
Patienta Gender
Age at Clinical
Measurement (y)
unless Otherwise
Noted
Blood
Pressure
(mm Hg)
Serum
Creatinine
(mg/dl) GFRb
Serum
Potassium
(mEq/L)c
Serum
Bicarbonate
(mEq/L)d
Serum Uric
Acid
(mg/dl)e
Fractional
Excretion
Uratef
DIV7 F 4 92/50 0.8 68j 4.6 21 6.0 0.01
DIV7 F 16 115/56 1.5 66k 5.2 22 4.4l 0.05
DIV3 M 8 102/50 0.9 68j 4.5 21 7.3 0.04
DIV3 M 20 120/70 1.8 72m 4.2 24 5.7l 0.04
DIII4 M 43 3.0 24m 4.6 22 4.1l
DIII6 M 47 120/85 2.5 38m 4.9 23 3.8l 0.05
BIV2 F 8 100/62 0.6 95k 4.6 24 5.1 0.03
BIII6 M 30 1.3 69m 4.6 27 9.9 0.04
BIII3 M 32 106/63 1.6 54m 4.3 29 6.5 0.03
BII4 F 59 1.8 31m 4.7 20
CIII2 F 12 100/50 1.3 63k 6 23 8.0
CIII4 F 16 110/60 1.2 83k 5.1 24 8.1l 0.03
CIII1 M 18 95/50 1.9 49m 5.7 28 10.5 0.03
CII5 M 42 135/70 1.6 51m 5.4 28 8.1l
CII3 F 45 125/80 1.1 57m 4.1 25 6.3l
CII1 M 48 120/70 1.5 53m 4.0 29 8.3l
a See Figure 1 for pedigree.
b GFR, glomerular filtration rate (ml/min/1.73 m2).
c Serum potassium normal range 3.5–5.0 mEq/L.
d Serum bicarbonate normal range 22–30 mEq/L.
e Serum uric acid normal values:34 adults, 2.5–8.0 mg/dl; children <5 years, 1.8–5.3 mg/dl; children 5 to 10 years, 2.1–6.1 mg/dl; female 12–1
f Fractional urate excretion normal values > 0.10 for children, > 0.05 for men, and > 0.06 for women.
g Hemoglobin normal range 11.5–13.5 g/dl for female children, 11.5–15.5 g/dl for male children, 12–16 g/dl for female adult, and 14–18 g/dl
h Plasma renin activity normal range 0.5–5.9 ng/ml/hr.
i Random serum aldosterone level normal range 3–28 ng/dL.
j Determined by inulin clearance.
k GFR determined by Schwartz Formula.36
l Determined while on allopurinol.
m Estimated by the Modification of Diet in Renal Disease Study equation.35
n Measured at age 16 prior to erythropoietin therapy.
o Active renin normal range 3.3–41 mU/L.
Figure 3. Bioinformatic Analysis of the
Preprorenin
(A) Diagram of the preprorenin sequence
showing the locations of the identiﬁed
mutations and epitopes recognized by
prorenin (amino acid residues 21–64) and
preprorenin (amino acid residues 288–
317) antibodies used in this study.
(B) Homology of the mutant and wild-type
human preprorenin signal sequences with
those of higher mammals.
(C) Hydrophobicity plot of the WTREN,
DL16REN, and L16RREN signal sequences
calculated via the Kyte and Doolittle
method and scale.Genotyping, Linkage Analysis, and DNA Sequencing
Revealed Mutations in the Signal Sequence
of Preprorenin
To identify the genetic defect, we corroborated the results of
the previous medium-dense scan in family A,6 performed
a genome-wide linkage analysis, and identiﬁed a single
genomic region with statistically signiﬁcant LOD score of
3.24 on chromosome 1 (Figure 1B). By using haplotype anal-
ysis, we delimited the candidate region between the SNP_A-
1517951andSNP_A-1509750markers. Thecritical regionwe
have delimited (genomic position chr1:188,333,009-
213,216,882) spans 25 million bases and contains about
300 genes. After the analysis of nine candidate genes re-
ported in our previous study,6 we sequenced promoter and
coding regions of six additional genes (ELF3 (ELF3 [MIM
602191]), ATF3 (ATF3 [MIM 603148]), KCNK2 (KCNK2
[MIM 603219]), KCTD3 (MIM n.a.); PTGS2 (PTGS2 [MIM
600262]), and REN (REN [MIM 179820]) and identiﬁed
a heterozygous deletion c.45_47delGCT in exon 1 of the
REN gene in the proband (Figure 1C). Genotyping showed
that the identiﬁed deletion was present in all affected indi-
viduals, whereas healthy individuals from the family as
well as 385 unrelatedwhite controls had a normal genotype.
Targeted REN sequencing among probands from other fami-
lies investigated in the Czech laboratory7 and families fol-
lowed by investigator A.J.B. revealed an additional family
(FamilyB) havingan identicalmutationpresentonadistinct
haplotype, indicating that the families are not related
(Supplemental Data available online). Family C of Portu-
guese origin,with amissensemutation c.47T>G(Figure 1D),
was revealed byM.M. andP.G. Thismutation also segregated
with the disease and was absent in 185 white controls and
50 controls from Portugal.
In Silico Analysis Suggested Altered Targeting
Properties of Mutant Renin Signal Sequences
Humanprorenin and renin are synthesized in juxtaglomer-
ular (JG) cells from a 406-amino-acid-residues-long prepro-
protein composed of a 23-residues-long N-terminal signal
sequence, 43-residues-long ‘‘pro’’ domain, and the mature
renin comprising 340 residues.4 Mutation c.45_47delGCTThe Americauses a deletion, p.Leu16del (DL16REN), whereas mutation
c.47T>G results in the amino acid exchange p.Leu16Arg
(L16RREN) of a single leucine residue, L16, forming a hydro-
phobic penta-leucine motif of the preprorenin signal
sequence mediating protein insertion in the ER membrane
(Figure 3A). The hydrophobic region of the humanprepror-
enin signal sequence is not entirely conserved among
mammals. However, the penta-leucinemotive is conserved
within primates (Figure 3B). With the SignalP 3.0 server,9
we noticed that both mutations decrease the signal
sequence prediction probability (D score value)15 and
have no effect on the predicted signal peptide cleavage
site (data not shown). Another calculation, theKyte-Doolit-
tle algorithm,10 showed a decrease in thehydrophobicity of
the DL16REN and L16RREN signal sequences compared to
that of the WTREN (Figure 3C).
Functional Studies Showed that Signal Sequence
Mutations Affect Renin Biosynthesis
WTREN, DL16REN, and L16RREN proteins were transiently
expressed in HEK293 cells and detected by western blot
analysis (Figure 4A). WTRENand DL16REN were expressed
as 47 kDa proteins whereas L16RREN was expressed as 45
kDa protein. Deglycosylation reduced molecular weight
of the WTRENand DL16REN proteins to 43 kDa, which
corresponds to complete loss of N-glycosylation on both
of the predicted N-glycosylation sites in the preprorenin
sequence (N71 and N141). Molecular weight of L16RREN
remained unchanged. Analysis of molecular weights sug-
gested that WTRENand DL16REN produce the signal
sequence-cleaved, ER-translocated, and fully glycosylated
prorenin whereas L16RREN produce nonglycosylated and
therefore secretion-incompetent and enzymatically inac-
tive preprorenin16 (Figure 4A).
Immunoﬂuorescence and confocal microscopy of trans-
fected cells demonstrated the expected localization of
rennin-containing granules in the cytosol of the investi-
gated cells. No visible differences in the amount, shape,
and cellular localization of WTREN, DL16REN, and L16RREN
granules were observed and/or detected by colocalization
with ER marker (Supplemental Data).can Journal of Human Genetics 85, 204–213, August 14, 2009 209
Figure 4. Functional Studies
(A) Western blot analysis of WTREN, DL16REN, and L16RREN proteins transiently expressed in HEK293 cells. Products of biosynthesis—
preprorenin (PreProREN) and prorenin (ProREN)—were analyzed in cell lysates and cell culturing medium. To distinguish proteolytic
processing and glycosylation status, the proteins were always analyzed before () and after (þ) deglycosylation with PNGase.
(B and C) In vitro translation and translocation.
(B) Nascent WTREN, DL16REN, and L16RREN proteins translated from corresponding mRNAs in nuclease-treated rabbit reticulocyte lysate
in the absence () or presence (þ) of rough endoplasmic reticulum microsomes (RM). Without RM, only nascent preprorenin (PrePro-
REN) is formed. With RM, the translocated preprorenin is converted into prorenin (ProREN). In comparing lane 2 to lane 4 (as well as
lanes 2 and 4 to lanes 6 and 8 in C), one can see that signiﬁcantly more WTREN is translocated into the RM and converted to prorenin
than with the DL16REN mutant. The difference in translocation efﬁciency between WTREN and DL16REN was assessed by densitometry.
The L16R mutation completely prevents translocation and L16RREN protein is present as preprorenin.
(C) Translation/translocation assay performed in the presence of RM and in the absence () or presence (þ) of the signal peptide pepti-
dase inhibitor (ZZ-L)2ketone. Upon centrifugation, prorenin as well as out cleaved signal peptide were present in RM pellet fractions (p),
whereas preprorenin that does not translocate is found in supernatant (s). The inhibitor only slightly affected preprorenin signal peptide
processing (lanes 4 and 8). Compared to DL16REN, the WTREN signal peptide is evidently more stable and only slightly affected by signal
peptide peptidase-mediated processing.
(D and E) Prorenin and renin produced by stably transfected HEK293 cells. Active renin (REN) and trypsin activated total renin þ pro-
renin (ProRENþREN) amountsmeasured in (D) lysates and (E) medium of the corresponding cell lines. The values representmeans5 SD
of the measurements performed in two independent clones for each of the constructs. The individual measurements were carried out in
triplicate. The statistical signiﬁcance of the differences between WTREN and DL16REN protein amounts was tested by t test. *p < 0.05;
**p < 0.01; ***p < 0.001. 0REN is an antibiotic-selected cell line originally transfected with WTREN construct, but showing later no renin
expression by RT-PCR and western blot analysis.
(F) Renin secretion from living stably transfected HEK293 cell lines. The ﬂuorescent signal is released from 5-FAM and QXL520 conju-
gated renin substrate and corresponds to the activity of renin secreted in the medium.
(G and H) Reduced growth rate (G) and activated XBP1 splicing (H) indicating ER stress in DL16REN-expressing cells.210 The American Journal of Human Genetics 85, 204–213, August 14, 2009
In vitro translation/translocation assays conﬁrmed that
L16RREN is not translocated across the ER membrane and
suggested a reduced translocation ability of DL16REN
(Figures 4B and 4C). The latter was supported by densitom-
etry analysis of the products obtained in three indepen-
dent experiments which demonstrated that only 39% of
the DL16REN precursor was processed to the 47 kDa form,
compared to 75% of the WTREN. In addition, an analysis
of the signal peptide processing (Figure 4C) showed that
compared to DL16REN, the WTREN signal peptide is evi-
dently more stable and only slightly affected by signal
peptide peptidase-mediated processing.
To assess prorenin and renin amounts produced by
DL16REN exactly, we prepared cell lines stably expressing
WTREN and DL16REN and measured prorenin and renin
production by quantitative radioimmunoassay. The anal-
ysis showed that DL16REN mutation signiﬁcantly impaired
prorenin and renin biosynthesis (Figure 4D), secretion
(Figure 4E), and activity (Figure 4F). Cells expressing
DL16REN also had a reduced growth rate (Figure 4G), acti-
vated endoplasmic reticulum stress, and unfolded protein
response, demonstrated by the presence of spliced X-Box
Protein 1 (XBP1) mRNA form17 (Figure 4H).
Ultrastructural analysis showed in theWTREN-expressing
cells numerous electron-dense cytoplasmic vesicles
compatible with those of previously reported secretory
renin granules18 (Figure 4I), whereas there was a decreased
number of cytoplasmic vesicles, considerable distension of
rough endoplasmic reticulum cisteranae, and pronounced
macroautophagy in DL16REN-expressing cells (Figure 4J).
Mutations Lead to Reduced Expression and Abnormal
Localization of Prorenin and Renin and Altered
Expression of RAS Components in Patient Kidney
Immunohistochemical staining with antibodies detecting
prorenin (amino acids residues 21–64); preprorenin, prore-
nin, and renin (amino acids residues 288–317); and active
renin (clone R3-36-16) was performed in kidney biopsies
from three patients with p.Leu16del mutation. Compared
to control tissues (Figures 2A–2C), staining for renin and
prorenin was strongly decreased in juxtaglomerular gran-
ular cells and undetectable in tubular cells in the early
disease stage (Figures 2D and 2E). In an advanced stage of
the disease, the signal was absent in both the juxtaglomer-
ular apparatus and the tubular epithelium (Figure 2F).
However, in all three patients we observed an abnormal
localization of both renin and prorenin inside the vessel
wall of several arterioles and small arteries (Figures 2G–2I).
Staining intensities of the other analyzed renal RAS compo-
nents—angiotensinogen, angiotensin II, and pro/renin
receptor—were decreased compared to controls. The
decreasewasproportional to the stageof thedisease (Supple-The Amerimental Data). No renin labeling was detected in the biopsy
specimen from patient CIII1 with p.Leu16Arg mutation by
immunohistochemical staining. According to in situ
hybridization, renin mRNA was not detected in juxtaglo-
merular cells but it was strongly expressed in sparse cells re-
garded as pericytes, along peritubular capillary (not shown).
Discussion
We identiﬁed twomutations, a deletion and an amino acid
exchange of a single leucine residue in the signal sequence
of renin segregating with a phenotype of anemia, hypour-
icosuric hyperuricemia, and slowly progressive chronic
kidney disease in three unrelated families.
Bioinformatic analysis showed thatbothmutationsaffect
the signal sequence properties and function. Functional
studies proved that L16RRENmutation prevents ER cotrans-
lational translocation and processing, which are necessary
for prorenin/renin secretion and activity.19 Instead, the
nascent preproprotein is synthesized and accumulates in
cytoplasm. In contrast, DL16REN mutation reduces translo-
cation efﬁciency of the nascent protein into ER and
decreases prorenin and renin biosynthesis and secretion.
Interestingly, the DL16REN mutation evidently reduces
signal peptide accumulation, which is suggestive that pre-
prorenin-derived signal peptide may fulﬁll a post-targeting
functionwithin theERmembraneor in adifferent compart-
ment as known for other signal peptides.20 Expression of
theDL16REN protein also signiﬁcantly affected cells growth,
activated ER stress, and unfolded protein response.
Clinical studies correlated these ﬁndings: immunohisto-
logic examination revealed a decrease in immunostaining
for renin in affected children, with an even more marked
decline with aging in juxtaglomerular cells and abnormal
localization/induction of both renin and prorenin inside
the vessel wall of arterioles, small arteries, and pericytes.
Patients were able to sustain plasma renin concentrations,
though low normal blood pressures in the setting of
chronic kidney disease and mild hyperkalemia suggested,
in agreement with immunohistochemistry analysis, a rela-
tive decrease in RAS activity.
Reduced fractional excretion of uric acid and resulting
hyperuricemia are consistent with a model of increased
proximal tubular reabsorption of uric acid resulting from
mild volume depletion because of relative aldosterone
deﬁciency. In contrast, if hyperuricemia was due to renal
insufﬁciency, the fractional excretion of uric acid would
have been elevated.21 Hyperuricemia resulting from
increased proximal tubular reabsorption of uric acid has
been seen in other genetic syndromes associated with
salt wasting and mild volume depletion such as uromodu-
lin-associated kidney disease.22(I and J) Electron microscopy of stably transfected HEK293 cell lines showing (I) overview of the WTREN -expressing cell with numerous
electron-dense granules (arrows) and (J) considerable distensions of ER cisternae (asterisk) observed frequently in DL16REN cells. Detail of
one of the autophagosomal structures is shown in the insert. These structures were not present in 0REN cells (data not shown).can Journal of Human Genetics 85, 204–213, August 14, 2009 211
Anemia is also consistent with decreased RAS activity.
Anemia has been noted in individuals receiving angio-
tensin converting enzyme inhibitors23 and diabetics with
hyporeninemic hypoaldosteronism.24 The degree of ane-
mia was out of proportion to the level of kidney failure;
one individual with normal renal function at age 8 years
suffered from persistent anemia since measurements per-
formed at age 1 year. The patients in this study were able
to reach target hemoglobin levels with use of erythropoi-
etin. It is unclear why the hemoglobin values tended to
be higher or normal in older individuals with the renin
mutation, though the increase in testosterone secretion
after adolescence may have been responsible in men.25
The ability of signal sequence mutations to activate ER
stress, unfolded protein response, and pronounced au-
tophagy has been noted with other signal sequence muta-
tions.26–30 These events usually reduce the client protein
expression rate, trigger apoptosis and inﬂammation, and
lead to a reduced viability of secretory cells31 and disease
development.32
In agreement with this model, we propose that the iden-
tiﬁed mutations in renin signal sequence likely expose
juxtaglomerular cells, sustaining the highest expression
rate of the mutant protein, to chronic ER stress and lead
to site-speciﬁc attenuation of renin biosynthesis and RAS
dysregulation. Reduced viability of juxtaglomerular cells
and limited renin availability then affect renal develop-
ment, intrarenal RAS homeostasis, and kidney autoregula-
tion resulting in anemia, reduced glomerular ﬁltration rate,
and hyperuricemia. Over time, accelerated apoptosis in
juxtaglomerular cells results, and, similar to mice with
ablated juxtaglomerular cells,33 nephron loss and progres-
sive kidney failure occurs. Proposed pathogenetic cascade
correlates with the clinical picture of slowly advancing
kidney failure, progressive tubulointerstitial nephropathy,
secondary focal and segmental glomerular sclerosis, and
nephron dropout demonstrated by nephropathologic
examination.
From a clinical perspective, our ﬁndings stress the
importance of renin analysis in families with early-onset
hyperuricemia, anemia, and progressive kidney failure.
We would be most interested in the referral of similar fami-
lies for genotyping.
Supplemental Data
Supplemental Data include three ﬁgures showing haplotype anal-
ysis in families A and B, expression of renal RAS components in
kidney biopsies, and cellular localization of the transiently ex-
pressed wild-type and mutant preprorenin, prorenin, and renin
in HEK293 cells and can be found with this article online at
http://www.ajhg.org/.
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